@article{HerrmannHildebrandMenzeletal.2019, author = {Herrmann, Marietta and Hildebrand, Maria and Menzel, Ursula and Fahy, Niamh and Alini, Mauro and Lang, Siegmund and Benneker, Lorin and Verrier, Sophie and Stoddart, Martin J. and Bara, Jennifer J.}, title = {Phenotypic characterization of bone marrow mononuclear cells and derived stromal cell populations from human iliac crest, vertebral body and femoral head}, series = {International Journal of Molecular Sciences}, volume = {20}, journal = {International Journal of Molecular Sciences}, number = {14}, issn = {1422-0067}, doi = {10.3390/ijms20143454}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-285054}, year = {2019}, abstract = {(1) In vitro, bone marrow-derived stromal cells (BMSCs) demonstrate inter-donor phenotypic variability, which presents challenges for the development of regenerative therapies. Here, we investigated whether the frequency of putative BMSC sub-populations within the freshly isolated mononuclear cell fraction of bone marrow is phenotypically predictive for the in vitro derived stromal cell culture. (2) Vertebral body, iliac crest, and femoral head bone marrow were acquired from 33 patients (10 female and 23 male, age range 14-91). BMSC sub-populations were identified within freshly isolated mononuclear cell fractions based on cell-surface marker profiles. Stromal cells were expanded in monolayer on tissue culture plastic. Phenotypic assessment of in vitro derived cell cultures was performed by examining growth kinetics, chondrogenic, osteogenic, and adipogenic differentiation. (3) Gender, donor age, and anatomical site were neither predictive for the total yield nor the population doubling time of in vitro derived BMSC cultures. The abundance of freshly isolated progenitor sub-populations (CD45-CD34-CD73+, CD45-CD34-CD146+, NG2+CD146+) was not phenotypically predictive of derived stromal cell cultures in terms of growth kinetics nor plasticity. BMSCs derived from iliac crest and vertebral body bone marrow were more responsive to chondrogenic induction, forming superior cartilaginous tissue in vitro, compared to those isolated from femoral head. (4) The identification of discrete progenitor populations in bone marrow by current cell-surface marker profiling is not predictive for subsequently derived in vitro BMSC cultures. Overall, the iliac crest and the vertebral body offer a more reliable tissue source of stromal progenitor cells for cartilage repair strategies compared to femoral head.}, language = {en} } @phdthesis{Matthes2008, author = {Matthes, Constanze}, title = {Immunmodulation Dendritischer Zellen durch Sekretionsprodukte mesenchymaler Stammzellen mit besonderem Focus auf hCyr61/CCN1}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-28129}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2008}, abstract = {Mesenchymale Stammzellen (MSC) sind starke Suppressoren des Immunsystems. F{\"u}r die immunsupressive Wirkung werden l{\"o}sliche Faktoren propagiert. In der vorliegenden Arbeit wurde untersucht, ob neben den bekannten Sekretionsfaktoren stromaler Stammzellen wie RANK/RANKL/OPG, TNF\&\#945;, IFN\&\#947; und verschiedene Interleukine, andere Sekretionsfaktoren eine immunmodulatorische Wirkung auf monozyt{\"a}re Zellen haben. Als Sekretionsprodukt wurde hCyr61 untersucht, das im {\"U}berstand von mit TNF\&\#945; behandelten humanen fetalen Osteoblasten (hFOB) nachgewiesen worden war. Das zur CCN-Familie geh{\"o}rende Protein hCyr61 ist an der Angiogenese beteiligt, wird im Kallus w{\"a}hrend der Frakturheilung vermehrt exprimiert und hat, wie zwischenzeitlich nachgewiesen wurde, einen deutlichen Effekt auf die Differenzierung endothelialer Vorl{\"a}uferzellen aus monozyt{\"a}ren Zellen. In den hier beschriebenen Experimenten wurden sowohl monozyt{\"a}re Zellen aus peripherem Blut (PBMC), als auch THP1-Zellen auf die Ver{\"a}nderung der CD14-, 80-, 83- und 86- Expression unter Stimulation mit und ohne Il-4, GM-CSF und hCyr61 untersucht. Die Expressions{\"a}nderung wurde mittels konventioneller PCR, real-time PCR und FACS-Analyse untersucht. In allen drei Nachweismethoden zeigte sich ein Verlust typisch monozyt{\"a}rer Marker wie CD14 unter Stimulation mit hCyr61. Der Verlust an CD14 scheint bei PBMC deutlicher als bei THP1-Zellen, was m{\"o}glicherweise durch die oben beschriebene endotheliale Differenzierung erkl{\"a}rt wird. THP1-Zellen befinden sich bereits in einer h{\"o}heren Differenzierungsstufe, sodass sie ihr monozyt{\"a}res Commitment nicht vollst{\"a}ndig verlieren.}, subject = {Immunmodulation}, language = {de} } @article{HerrmannDiederichsMelniketal.2021, author = {Herrmann, Marietta and Diederichs, Solvig and Melnik, Svitlana and Riegger, Jana and Trivanović, Drenka and Li, Shushan and Jenei-Lanzl, Zsuzsa and Brenner, Rolf E. and Huber-Lang, Markus and Zaucke, Frank and Schildberg, Frank A. and Gr{\"a}ssel, Susanne}, title = {Extracellular Vesicles in Musculoskeletal Pathologies and Regeneration}, series = {Frontiers in Bioengineering and Biotechnology}, volume = {8}, journal = {Frontiers in Bioengineering and Biotechnology}, issn = {2296-4185}, doi = {10.3389/fbioe.2020.624096}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-222882}, year = {2021}, abstract = {The incidence of musculoskeletal diseases is steadily increasing with aging of the population. In the past years, extracellular vesicles (EVs) have gained attention in musculoskeletal research. EVs have been associated with various musculoskeletal pathologies as well as suggested as treatment option. EVs play a pivotal role in communication between cells and their environment. Thereby, the EV cargo is highly dependent on their cellular origin. In this review, we summarize putative mechanisms by which EVs can contribute to musculoskeletal tissue homeostasis, regeneration and disease, in particular matrix remodeling and mineralization, pro-angiogenic effects and immunomodulatory activities. Mesenchymal stromal cells (MSCs) present the most frequently used cell source for EV generation for musculoskeletal applications, and herein we discuss how the MSC phenotype can influence the cargo and thus the regenerative potential of EVs. Induced pluripotent stem cell-derived mesenchymal progenitor cells (iMPs) may overcome current limitations of MSCs, and iMP-derived EVs are discussed as an alternative strategy. In the last part of the article, we focus on therapeutic applications of EVs and discuss both practical considerations for EV production and the current state of EV-based therapies.}, language = {en} } @phdthesis{Ege2023, author = {Ege, Carolin}, title = {Einfluss der Phosphodiesterase 10A auf cAMP-abh{\"a}ngige Signalwege und deren Effekt auf osteogene Differenzierung und Mechanotransduktion von mesenchymalen Stromazellen}, doi = {10.25972/OPUS-32832}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-328327}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2023}, abstract = {Humane mesenchymale Stromazellen sind in der Lage in osteogene Zellen zu differenzieren, und f{\"u}r diese osteogene Differenzierung ist mechanische Belastung ein relevanter Kostimulus. Mechanotransduktion hat zur Folge, dass second messenger wie cAMP und cGMP gebildet werden und sich die Ca2+-Konzentration erh{\"o}ht, welche wiederum Transkriptionsfaktoren aktivieren, die die Regulation von Genen osteogener Marker vermitteln. Die second messenger cAMP und cGMP werden abgebaut durch Phosphodiesterasen, jedoch ist die Rolle dieser Phosphodiesterasen w{\"a}hrend der osteogenen Differenzierung oder Mechanotransduktion weiterhin unklar. Das Ziel dieser Arbeit war es, herauszufinden, inwieweit im Besonderen die Phosphodiesterase 10A einen Einfluss nimmt auf die osteogene Differenzierung und die Mechanotransduktion von mesenchymalen Stromazellen und inwiefern sie dabei die cAMP-abh{\"a}ngigen Signalwege moduliert. Langfristig soll hiermit herausgefunden wer-den, welche Bedeutung die PDE10A auf altersinduzierte Krankheiten hat, wobei der Fokus zun{\"a}chst auf der Osteoporose liegen soll. Um dies zu erreichen, wurden experimentelle Versuche zun{\"a}chst mit HEK293- und hMSC-TERT-Zellen als Modell f{\"u}r mesenchymale Stromazellen durchgef{\"u}hrt, dann auch mit den mesenchymalen Stromazellen selbst. Untersucht wurde der Einfluss des PDE10A-Inhibitors Papaverin auf die Zellen und auf deren mechanische Induzierbarkeit, sowieso auf die osteogene Differenzierung der hMSC. Außerdem wurden weitere mechanische Versuche durchgef{\"u}hrt, zur {\"U}berpr{\"u}fung des Effekts der Phosphodiesterase 10A. Es wurde beobachtet, dass die Inhibierung von PDE10A mit Papaverin die osteogene Differenzierung und Mineralisierung vermindert. Außerdem gab es einen ersten Hinweis, dass eine {\"U}berexpression von PDE10A schw{\"a}chenden Einfluss nimmt auf die Expression mechanoresponsiver Gene. Nachfolgend auf diese Arbeit wurde erkannt, dass die Expression von mechanoresponsiven Genen durch die PDE10A-Inhibition unterdr{\"u}ckt wird.}, subject = {Mesenchymzelle}, language = {de} } @phdthesis{HaddadWeber2010, author = {Haddad-Weber, Meike}, title = {Development of stem cell-based ACL- and tendon reconstruction}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-66796}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2010}, abstract = {Ruptures of the anterior cruciate ligament (ACL) and defects of the rotator cuff represent the most common ligament and tendon injuries in knee and shoulder. Both injuries represent significant implications for the patients. After an injury, the ACL and the rotator cuff both exhibit poor intrinsic healing capacities. In order to prevent further defects such as arthritis of the knee and fatty infiltration of the rotator cuff, surgical interaction is essential. In both cases, the currently used surgical techniques are far from optimal because even after the therapy many patients report problems ranging from pain and reduced mobility to complete dysfunction of the involved joint and muscles. Tissue engineering may be a possible solution. It is a promising field of regenerative medicine and might be an advantageous alternative for the treatment of musculoskeletal injuries and diseases in the near future. In this thesis, different tissue engineering based approaches were investigated. For the reconstruction of damaged or diseased ligaments and tendons, the use of MSCs and gene therapy with growth factors is especially suitable and possesses a great therapeutic potential. Therefore, the first method studied and tested in this thesis was the development of a biomaterial based construct for the repair of a ruptured ACL. The second approach represents a cell based strategy for the treatment of the fatty infiltration in the rotator cuff. The third approach was a combined cell, biomaterial, and growth factor based strategy for ACL ruptures. Biomaterial based ACL construct The implant is currently tested in a preclinical in vivo study in mini pigs. This proof-of-principle study is performed to validate the functional capability of the collagen fiber based implant under load in vivo and its population with fibroblasts which produce a ligamentogenic matrix. Cell based treatment of the fatty infiltration in the rotator cuff Regarding the treatment of the fatty infiltration of the rotator cuff in a rabbit model, the in vivo results are also promising. The group treated with autologous MSCs (+MSC group) showed a lower fat content than the untreated group (-MSC group) 6 weeks after the treatment. Furthermore, the SSP muscle of the MSC-treated animals revealed macroscopically and microscopically only few differences compared to the healthy control group. The exact underlying mechanisms leading to the positive results of the treatment are not yet fully understood and have therefore to be further investigated in the future. Cell, biomaterial, and growth factor based treatment of ACL ruptures Studies described in current literature show that collagen hydrogel scaffolds are not ideal for a complete ligament or tendon reconstruction, because of their insufficient mechanical stability. Introduced as an alternative and superior therapy, the combined strategy used in this thesis proves that the cultivation of BMP-12, -13, and IGF-1 transduced MSCs and ACL fibroblasts in a collagen hydrogel is successful. The results of the performed in vitro study reveal that the cells exhibit a fibroblastic appearance and produce a ligamentogenic matrix after 3 weeks. Furthermore, the adenoviral transduction of MSCs and ACL fibroblasts showed no negative effects on proliferation or viability of the cells nor was apoptosis caused. Therefore, the application of these cells represents a possible future therapy for a partial ligament and tendon rupture where the mechanical stability of the remaining ligament or tendon is sufficient and the healing can be improved substantially by this therapy. In general, prospective randomized clinical trials still have to prove the postulated positive effect of MSCs for the treatment of various musculoskeletal diseases, but the results obtained here are already very promising. Ideally, the treatment with MSCs is superior compared to the standard surgical procedures. Because of current safety issues the use of genetically modified cells cannot be expected to be applied clinically in the near future. In summary, the different tissue engineering approaches for novel therapies for musculoskeletal injuries and diseases invested in this thesis showed very promising results and will be further developed and tested in preclinical and clinical trials.}, subject = {Kreuzband}, language = {en} }